Bavarian Nordic raises 2022 annual guidance again after monkeypox vaccine deals | Reuters
Danish biotechnology company Bavarian Nordic revised its annual guidance on Monday for a second time after signing supply contracts with several undisclosed countries for its Imvanex monkeypox vaccine.
